Dr. Roloff’s interest in hematology/oncology blossomed as an undergraduate and medical student. Along the way, he spent two years conducting translational research at NIH, initially focused on spatial organization of cancer genomes and subsequently, on measurable residual disease in acute myeloid leukemia as part of the NIH Medical Research Scholars Program. He moved to Chicago in 2018 to begin my clinical training at Loyola University Medical Center, where he further solidified his interest in the care of patients with blood cancers. The University of Chicago’s highly esteemed leukemia and cell therapy programs and rich institutional research environment served as strong forces that drew him to our Fellowship. Currently, his research is focused on the use of next-generation sequencing technologies to augment clinical decision making in hematologic malignancies. HIs immediate career goal is to earn an Assistant Professorship at a Comprehensive Cancer Center and look after patients with leukemia and those undergoing hematopoietic cell transplant. Outside of work, he enjoys running on the lakefront, lifting weights, petting dogs, golfing, and eating guacamole, in no particular order.
